 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/13/2019 |
$80.34 |
$81.32 |
$80.29 |
$80.79 |
4.24M | | 02/14/2019 |
$80.45 |
$80.68 |
$79.72 |
$80.52 |
3.44M | | 02/15/2019 |
$81.13 |
$81.70 |
$80.16 |
$80.85 |
6.30M | | 02/19/2019 |
$80.50 |
$81.52 |
$80.23 |
$80.52 |
5.67M | | 02/20/2019 |
$80.53 |
$80.60 |
$79.14 |
$79.99 |
5.52M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on February 13, 2019, ABBV opened at $80.34, traded as high as $81.32 and as low as $80.29, and closed at $80.79. Trading volume was a total of 4.24M shares. On February 14, 2019, ABBV opened at $80.45, traded as high as $80.68 and as low as $79.72, and closed at $80.52. Trading volume was a total of 3.44M shares. On February 15, 2019, ABBV opened at $81.13, traded as high as $81.70 and as low as $80.16, and closed at $80.85. Trading volume was a total of 6.30M shares. On February 19, 2019, ABBV opened at $80.50, traded as high as $81.52 and as low as $80.23, and closed at $80.52. Trading volume was a total of 5.67M shares. On February 20, 2019, ABBV opened at $80.53, traded as high as $80.60 and as low as $79.14, and closed at $79.99. Trading volume was a total of 5.52M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/20/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$79.99 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
358.08 |
|
| Dividends reinvested/share: |
$14.78 |
|
| Total return: |
186.43% |
|
| Average Annual Total Return: |
18.70% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$28,635.39 |
|
| Years: |
6.14 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
02/20/2019 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$79.99 |
|
| Dividends collected/share: |
$14.78 |
|
| Total return: |
169.85% |
|
| Average Annual Total Return: |
17.56% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$26,988.71 |
|
| Years: |
6.14 |
|
|
|
| Date |
Close |
| 02/13/2019 | $80.79 | | 02/14/2019 | $80.52 | | 02/15/2019 | $80.85 | | 02/19/2019 | $80.52 | | 02/20/2019 | $79.99 |
|
|
